The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchRash, joint pain or autoimmune flare.
How Vilon works
The simplest Khavinson dipeptide bioregulator — immune modulation and lifespan effects in aging models.
Lys-Glu — a two-amino-acid peptide, the simplest bioregulator there is. Proposed to modulate immune function and, in the animal work, to shift gene expression in aged tissue.
- Injectable
On the goal map: Liver, kidney, gut & lung (Organ-specific bioregulation)
Research on Vilon5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
The most-studied of the synthetic dipeptides within the Khavinson literature, with reported lifespan extension in mice and rats and immune effects in aged animals. Human use is longstanding in Russia and negligible elsewhere.
How the mechanism reads
Lys-Glu — a two-amino-acid peptide, the simplest bioregulator there is. Proposed to modulate immune function and, in the animal work, to shift gene expression in aged tissue.
Experimental, animal or cellThe shared claim across the Khavinson series: peptides this short are proposed to enter the cell nucleus and bind promoter regions of DNA, shifting tissue-specific gene expression.
MechanisticA dipeptide is where the mechanism is most plausible and least impressive at once: it is small enough to conceivably reach the nucleus, and too small to carry much sequence-specific information. That tension is the honest state of the hypothesis.
Mechanistic
Sources
- Khavinson VK. KE peptide regulates SIRT1, PARP1, PARP2 gene expression and protein synthesis in human mesenchymal stem cells aging. Advances in Gerontology 2023 [Russian] · PMID 37782636
- Pliss GB. Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats. Bulletin of Experimental Biology and Medicine 2001 · PMID 11586406
- Raikhlin NT. Expression of argyrophilic proteins in the nucleolar organizer regions of human thymocytes and thymic epitheliocytes under conditions of coculturing with vilon and epithalon peptides. Bulletin of Experimental Biology and Medicine 2004 · PMID 15455093
- Linkova N. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International Journal of Molecular Sciences 2023 · PMID 37686182
- Kolchina N, Khavinson V, Linkova N, Yakimov A, Baitin D, Afanasyeva A, Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research 2019;47(20):10553–10563 · PMID 31598715
- Khavinson VK, Anisimov VN, Zavarzina NY, Zabezhinskii MA, Zimina OA, Popovich IG, Shtylik AV, Malinin VV, Morozov VG. Effect of vilon on biological age and lifespan in mice. Bulletin of Experimental Biology and Medicine 2000;130(1):687–690
- Khavinson VKh, Rybakina EG, Malinin VV, Pivanovich IY, Shanin SN, Korneva EA. Effects of short peptides on thymocyte blast transformation and signal transduction along the sphingomyelin pathway. Bulletin of Experimental Biology and Medicine 2002;133(5):497-499 · PMID 12420072
Vilon safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Active autoimmune disease: even the simplest immune dipeptide could shift T-cell balance.
- Anti-rejection drugs after a transplant: an immune dipeptide pulls against them.
- Pregnancy or breastfeeding: no data for Lys-Glu.
- Allergy to short peptides.
What’s expected
- Often nothing felt; the claim is immune modulation, with lifespan effects only in animal ageing models.
- Tiredness or a low fever for a day in some users.
- Mild soreness where it is applied while using Vilon.
Watch for
- Rash, joint pain or autoimmune flare.
- Persistent fever while using Vilon.
- Swollen glands.
- Hives while using Vilon.
Labs that tell you it’s working
- Complete Blood Count (CBC) w/ Differential
- hs-CRP (C-Reactive Protein, High Sensitivity)
- ESR (Sed Rate, Westergren)
- ANA (Antinuclear Antibodies, IFA)
Vilon is the Lys-Glu dipeptide, the simplest Khavinson bioregulator, with immune and lifespan effects in animals; lymphocytes and autoimmunity are the checks.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Vilon FAQ4 common questions
- Is Vilon approved for human use?
- No. Vilon is a research compound.
- What is Vilon researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Complete Blood Count; hs-CRP; ESR; ANA: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Vilon: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



